Biogen, Inc. (NASDAQ/BGEN) today announced that Frank A. Burke, Jr., has been appointed Executive Vice President, Human Resources. Mr. Burke reports to James C. Mullen, President and Chief Executive Officer.

Mr. Burke joined Biogen in 1986 after a 12-year career with Allied Signal Corporation. He has supervised the global human resources function throughout Biogen’s growth from a boutique research organization into a multi-product global biopharmaceutical company.

Mr. Mullen said, “Frank Burke is an outstanding professional who has devoted much of his career to building Biogen. He continues to meet the considerable challenges of managing the human resources aspects of a dynamic and rapidly growing organization and will play a key role in the ongoing evolution of our company.”

Biogen, Inc., winner of the U.S. National Medal of Technology, is a biopharmaceutical company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. Headquartered in Cambridge, MA, the Company’s revenues are generated from international sales of AVONEX® (Interferon beta-1a) for treatment of relapsing forms of multiple sclerosis, and from the worldwide sales by licensees of a number of products, including alpha interferon and hepatitis B vaccines and diagnostic products. Biogen’s research and development activities are focused on novel products to treat inflammatory and autoimmune diseases, neurological diseases, cancer, fibrosis and congestive heart failure. The Company maintains active clinical research programs in protein therapeutics, small molecules, genomics and gene therapy. For copies of press releases and additional information about the Company, please consult Biogen’s Homepage on the World Wide Web at